Grandfield & Dodd LLC Purchases 76,035 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Grandfield & Dodd LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 298,885 shares of the company’s stock after acquiring an additional 76,035 shares during the quarter. GE HealthCare Technologies makes up approximately 1.6% of Grandfield & Dodd LLC’s holdings, making the stock its 24th largest position. Grandfield & Dodd LLC owned 0.07% of GE HealthCare Technologies worth $23,110,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Barclays PLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $92,462,000. Thrivent Financial for Lutherans purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $1,590,000. MML Investors Services LLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $929,000. Schonfeld Strategic Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $3,474,000. Finally, Tower Research Capital LLC TRC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $1,150,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

GEHC traded down $0.48 during mid-day trading on Friday, reaching $84.49. 2,022,710 shares of the company traded hands, compared to its average volume of 2,568,032. The stock has a market capitalization of $38.56 billion, a P/E ratio of 27.98, a P/E/G ratio of 2.96 and a beta of 0.94. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. The company’s fifty day moving average price is $88.74 and its 200-day moving average price is $77.82. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 EPS. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. HSBC started coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.